AWM
ACHV icon

Avior Wealth Management’s Achieve Life Sciences ACHV Stock Holding History

Avior Wealth Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-480
Closed -$2K – 1133
2022
Q2 		$2K Buy
+480
New +$3.26K ﹤0.01% 926

Other funds holding ACHV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Avior Wealth Management's ACHV Position: Q3 2022 in Review

Avior Wealth Management sold out of Achieve Life Sciences (ACHV) in Q3 2022, closing a stake of 480 shares — an estimated $2K sold.

Avior Wealth Management first reported a position in ACHV in Q2 2022 and held it in 1 quarter. The position peaked at $2K in Q2 2022. 28 funds tracked by Wall St. Rank hold ACHV as of Q3 2022.

  • Avior Wealth Management reported no remaining Achieve Life Sciences position as of Q3 2022 after selling out during the quarter.
  • Avior Wealth Management sold 480 Achieve Life Sciences shares in Q3 2022, an estimated $2K.
  • Avior Wealth Management first reported a position in Achieve Life Sciences in Q2 2022 and held it in 1 quarter.
  • Avior Wealth Management's Achieve Life Sciences position peaked at $2K in Q2 2022.
  • 28 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2022.

Based on Avior Wealth Management's 13F filing for Q3 2022, filed 26 Oct 2022.